Special Issue "Marine Compounds and Inflammation II, 2017"
A special issue of Marine Drugs (ISSN 1660-3397).
Deadline for manuscript submissions: closed (31 December 2017)
Prof. Dr. Olivier P. Thomas
National University of Ireland Galway, Marine Biodiscovery, School of Chemistry, University Road, Galway, Ireland
Website | E-Mail
Phone: +353 91 493 563
Interests: marine natural product chemistry; marine drugs; marine sponges; marine cyanobacteria and algae, structure elucidation; chemical ecology; metabolomics
Inflammation is a natural process which is part of the response mechanisms of an organism to pathogenic factors, with the function to circumvent or eliminate the cause of the cell injury or tissue damage. However, when uncontrolled, inflammatory processes may lead to severe diseases such as atherosclerosis, diabetes, arthritis, inflammatory bowel disease, cancer and Alzheimer. Research in the area of inflammation is very active with the availability and advancement of various types of in-vitro and in-vivo inflammatory models. For instance, key enzymes involved in these inflammation processes have been identified, and as such, they represent new targets for future anti-inflammatory compounds. In this regard, with an almost endless plethora of chemodiversity, marine organisms offer tremendous potential for drug discovery projects against diseases associated with inflammation. In the capacity of Guest Editor for this Special Issue of Marine Drugs, I invite you to submit your research findings on the anti-inflammatory potential of marine resources ranging from isolation and structure elucidation of new marine natural products with anti-inflammatory potential, to the mechanistic studies of known compounds in this area.
Prof. Dr. Olivier P. Thomas
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Marine natural products
- Drug discovery
- Anti-inflammatory effects
- Bioactive compounds
- Marine pharmaceuticals
- Autoimmune diseases
- Intracellular signaling pathways